Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
US7081238B2 · kind B2 · utility
5Cited by
14References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 17, 2001 |
| Grant date | Jul 25, 2006 |
| Priority date | — |
| Expiry date | Jan 6, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/0478
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of diagnosing attention deficient-hyperactivity disorder (ADHD) in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where an elevated level of dopamine transporter in the patient is indicative of ADHD. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.